<div class="textLayer" style="width:800px; height:1136.38722716249px;"><div style="left: 683.3548908649959px; top: 1103.5516496901103px; font-size: 8.794933980059282px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.9231723857016026);">Innovation for patient care</div><div style="left: 783.9153866882243px; top: 1106.4790619779033px; font-size: 5.196308272702776px; font-family: 'Open Sans', sans-serif;">*</div><div style="left: 773.9854486661277px; top: 1049.9591754244136px; font-size: 9.431420102398276px; font-family: 'Open Sans', sans-serif; transform: rotate(-90deg) scaleX(0.7395454448512425);">* Innover pour mieux soigner</div><div style="left: 97.69334411209917px; top: 1065.2631366208568px; font-size: 16.168148746968473px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.047999231244423);">Pour plus d’informations, consultez la notice du médicament.</div><div style="left: 430.1818916734034px; top: 63.33468067906206px; font-size: 21.55753166262463px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.08344110392885);">L.P. 3 mg, L.P. 11,25 mg</div><div style="left: 430.1818916734034px; top: 84.89221234168663px; font-size: 21.55753166262463px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0901430374174614);">et L.P. 22,5 mg</div><div style="left: 342.84289948800864px; top: 122.74184855833987px; font-size: 40.42037186742118px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.999279348875707);">GUIDE  </div><div style="left: 56.92912961465913px; top: 168.15494475882497px; font-size: 24.656426839126922px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0592879277849419);">pour la préparation et l’administration de Décapeptyl</div><div style="left: 699.7359202371329px; top: 169.8969345189974px; font-size: 14.374696847210995px; font-family: 'Open Sans', sans-serif;">®</div><div style="left: 711.2341686876853px; top: 168.15494475882497px; font-size: 24.656426839126922px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.9320306681270535);"> L.P.</div><div style="left: 40.30005389382916px; top: 249.26569657774158px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0993351719765407);">Décapeptyl L.P. 3 mg, poudre et solvant pour suspension injectable (I.M.) forme à libération prolongée sur </div><div style="left: 40.30005389382916px; top: 265.4338453247101px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0661325570111595);">28 jours.</div><div style="left: 98.12180005389385px; top: 266.6597817299917px; font-size: 7.855025599568849px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.318351657574486);">(1)</div><div style="left: 40.2949339800593px; top: 285.91350040420355px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8627860139860143);">Indications  :  Cancer  de  la  prostate  :</div><div style="left: 252.7041228779305px; top: 286.1694960926972px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8135589089855545);">Traitement  du  cancer  de  la  prostate  localement  avancé,  seul  ou  en  traitement  concomitant  et  </div><div style="left: 40.2949339800593px; top: 302.33764483966564px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8654334504677551);">adjuvant à la radiothérapie. Traitement du cancer de la prostate métastatique. Un effet favorable du médicament est d’autant plus net </div><div style="left: 40.2949339800593px; top: 318.5057935866342px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8463054037866842);">et plus fréquent que le patient n’a pas reçu auparavant un autre traitement hormonal.</div><div style="left: 499.1201832390191px; top: 318.2497978981405px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.9083836555156852);">Puberté précoce : </div><div style="left: 602.2864457019671px; top: 318.5057935866342px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.862916560357472);">(avant 8 ans chez la fille, avant </div><div style="left: 40.2949339800593px; top: 334.6739423336026px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8500728774334078);">10 ans chez le garçon). </div><div style="left: 163.53664780382653px; top: 334.41794664510894px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8948302314722169);">Endométriose : </div><div style="left: 251.78779304769614px; top: 334.6739423336026px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8482080974808788);">à localisation génitale et extragénitale (du stade I au stade IV) : La durée du traitement est limitée </div><div style="left: 40.2949339800593px; top: 350.84209108057115px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.7984235944700445);">à  6  mois  (cf.  Effets  indésirables).  Il  n’est  pas  souhaitable  d’entreprendre  une  seconde  cure  par  la  triptoréline  ou  par  un  autre  analogue  </div><div style="left: 40.2949339800593px; top: 367.0102398275396px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.7967135981727712);">de  la  GnRH.</div><div style="left: 109.45432497978982px; top: 366.7542441390459px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.892915951330392);">Infécondité  féminine  : </div><div style="left: 242.8146052277014px; top: 367.0102398275396px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8140772961774378);">Traitement  complémentaire,  en  association  avec  les  gonadotrophines  (hMG,  FSH,  hCG),  au  cours  </div><div style="left: 40.2949339800593px; top: 383.178388574508px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8497421148036255);">d’une induction de l’ovulation en vue d’une fécondation </div><div style="left: 336.35798976017253px; top: 383.178388574508px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8351524796861866);">in vitro </div><div style="left: 375.5765292374024px; top: 383.178388574508px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8601759088555152);">suivie d’un transfert d’embryon (FIVETE). </div><div style="left: 594.1254378873621px; top: 382.92239288601434px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.9095135690085898);">Traitement pré-opératoire des </div><div style="left: 40.2949339800593px; top: 399.0905416329829px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.902071681619508);">fibromes utérins : </div><div style="left: 143.48544866612772px; top: 399.34653732147655px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8411472606863324);">associés à une anémie (avec un taux d’hémoglobine inférieur ou égal à 8 g/dl), dans le cas où une réduction de la taille </div><div style="left: 40.2949339800593px; top: 415.514686068445px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8411455795334556);">du fibrome est nécessaire pour faciliter ou modifier la technique opératoire : chirurgie endoscopique, chirurgie transvaginale. La durée du </div><div style="left: 40.2949339800593px; top: 431.6828348154135px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8526336242473449);">traitement est limitée à 3 mois.</div><div style="left: 40.2949339800593px; top: 450.90945836701667px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0941868918772248);">Décapeptyl L.P. 11,25 mg, poudre et solvant pour suspension injectable (I.M.) forme à libération prolongée </div><div style="left: 40.2949339800593px; top: 467.0776071139852px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0498172594640984);">sur 3 mois.</div><div style="left: 112.05739692805176px; top: 468.31701697655586px; font-size: 7.855025599568849px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.2878161234991428);"> (2)</div><div style="left: 40.30005389382916px; top: 487.57477768795445px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8627860139860143);">Indications  :  Cancer  de  la  prostate  :</div><div style="left: 252.7095122608461px; top: 487.8307733764481px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8135567898679684);">Traitement  du  cancer  de  la  prostate  localement  avancé,  seul  ou  en  traitement  concomitant  et  </div><div style="left: 40.30005389382916px; top: 503.99892212341666px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8486621146387441);">adjuvant à la radiothérapie. Traitement du cancer de la prostate métastatique. Un effet favorable du médicament est d’autant plus net et </div><div style="left: 40.30005389382916px; top: 520.1670708703851px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8280103376239978);">plus fréquent que le patient n’a pas reçu auparavant un autre traitement hormonal. </div><div style="left: 475.7662355160332px; top: 519.9110751818914px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8948934227816588);">Endométriose :</div><div style="left: 560.8915386688222px; top: 520.1670708703851px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.852735605055891);"> à localisation génitale et extragénitale </div><div style="left: 40.30005389382916px; top: 536.3352196173536px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8389997240793787);">(du stade I au stade IV). La durée du traitement est limitée à 6 mois (voir rubrique 4.8). Il n’est pas souhaitable d’entreprendre une seconde </div><div style="left: 40.30005389382916px; top: 552.5033683643221px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8454003665952892);">cure par la triptoréline ou par un autre analogue de la GnRH. </div><div style="left: 364.96725949878726px; top: 552.2473726758284px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.9180053636472801);">Puberté précoce centrale :</div><div style="left: 515.8497709512258px; top: 552.5033683643221px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8812054764412292);"> (avant 8 ans chez la fille, avant 10 ans chez le </div><div style="left: 40.30005389382916px; top: 568.6715171112905px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8361421573736321);">garçon).</div><div style="left: 40.30005389382916px; top: 587.8981406628939px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0931713202094993);">Décapeptyl L.P. 22,5 mg, poudre et solvant pour suspension injectable à libération prolongée.</div><div style="left: 676.7569388305039px; top: 589.1321611425489px; font-size: 7.855025599568849px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.2878161234991428);"> (3)</div><div style="left: 40.30005389382916px; top: 608.3912691996765px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.909512100139082);">Indications :</div><div style="left: 109.13459983831854px; top: 608.6472648881702px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8567974369708401);"> Traitement du cancer de la prostate hormono-dépendant localement avancé ou métastatique. Décapeptyl L.P. 22,5 mg est </div><div style="left: 40.30005389382916px; top: 624.8154136351386px; font-size: 13.473457289140393px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8436648973412044);">indiqué en traitement concomitant et adjuvant à la radiothérapie du cancer de la prostate hormono-dépendant localement avancé.</div><div style="left: 37.67421180274859px; top: 1018.5542980328751px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8027072147806004);">1) RCP Décapeptyl</div><div style="left: 110.8447857720291px; top: 1019.2844192939906px; font-size: 6.284020479655079px; font-family: 'Open Sans', sans-serif;">®</div><div style="left: 114.32902182700082px; top: 1018.5542980328751px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.7681266603235014);"> L.P. 3 mg.</div><div style="left: 37.672460253301px; top: 1030.6804095931013px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8027072147806004);">2) RCP Décapeptyl</div><div style="left: 110.8447857720291px; top: 1031.410530854217px; font-size: 6.284020479655079px; font-family: 'Open Sans', sans-serif;">®</div><div style="left: 114.32902182700082px; top: 1030.6804095931013px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.800247564197714);"> L.P. 11,25 mg.</div><div style="left: 37.672460253301px; top: 1042.8059822150362px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.8027072147806004);">3) RCP Décapeptyl</div><div style="left: 110.8447857720291px; top: 1043.5361034761518px; font-size: 6.284020479655079px; font-family: 'Open Sans', sans-serif;">®</div><div style="left: 114.32902182700082px; top: 1042.8059822150362px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.7895212289685442);"> L.P. 22,5 mg.</div><div style="left: 74.32578819725143px; top: 744.0918889787118px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.009917485265226);">Formulation </div><div style="left: 147.37348423605496px; top: 743.4977095122607px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.140351485218373);">28 jours (3 mg)</div><div style="left: 85.05739692805176px; top: 758.0490433845322px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0616853679358034);">VOIE INTRAMUSCULAIRE</div><div style="left: 309.86391808137967px; top: 744.0918889787118px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.009917485265226);">Formulation </div><div style="left: 382.9116141201832px; top: 743.4977095122607px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.138940638184087);">3 mois (11,25 mg)</div><div style="left: 329.4960926973862px; top: 758.0490433845322px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0616853679358034);">VOIE INTRAMUSCULAIRE</div><div style="left: 558.0490433845325px; top: 744.0918889787118px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.009917485265226);">Formulation </div><div style="left: 631.096739423336px; top: 743.4977095122607px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.1432857325328905);">6 mois (22,5 mg)</div><div style="left: 573.9342495284291px; top: 758.0490433845322px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0616853679358034);">VOIE INTRAMUSCULAIRE</div><div style="left: 268.36162759364055px; top: 792.1463217461599px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.6484669738863287);">• </div><div style="left: 279.6577741848559px; top: 792.6744812718941px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0805357694064472);">1 flacon contenant la poudre de Décapeptyl</div><div style="left: 516.2153058474805px; top: 793.4360657504714px; font-size: 6.284020479655079px; font-family: 'Open Sans', sans-serif;">®</div><div style="left: 521.2422527620588px; top: 792.6744812718941px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.9320306681270536);"> L.P.</div><div style="left: 313.52465642683916px; top: 805.0808407437347px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.6484669738863287);">• </div><div style="left: 324.8208030180544px; top: 805.609000269469px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0627359893404398);">1 ampoule contenant le solvant</div><div style="left: 370.1670708703853px; top: 818.0153597413093px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.6484669738863287);">• </div><div style="left: 381.46321746160055px; top: 818.5435192670436px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0412584269662921);">1 seringue</div><div style="left: 127.74184855834008px; top: 851.8067906224735px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0218651841556639);">2 AIGUILLES</div><div style="left: 372.1719213150094px; top: 851.8067906224735px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0218651841556639);">2 AIGUILLES</div><div style="left: 616.6019940716787px; top: 851.8067906224735px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0218651841556639);">2 AIGUILLES</div><div style="left: 48.22985718135273px; top: 884.3761789275126px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0133345816266826);">RECONSTITUTION</div><div style="left: 185.642683912692px; top: 884.3761789275126px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0965539452495976);">INJECTION</div><div style="left: 288.8480194017785px; top: 884.3761789275126px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0133345816266826);">RECONSTITUTION</div><div style="left: 433.9005658852061px; top: 884.3761789275126px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0965539452495976);">INJECTION</div><div style="left: 537.1059013742927px; top: 884.3761789275126px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0133345816266826);">RECONSTITUTION</div><div style="left: 674.5189975747776px; top: 884.3761789275126px; font-size: 12.126111560226354px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0965539452495976);">INJECTION</div><div style="left: 70.43398005928321px; top: 925.6036108865533px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif;">•</div><div style="left: 78.39948800862302px; top: 926.1317704122876px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.062111878760865);"> 1 aiguille</div><div style="left: 59.76300188628403px; top: 939.0662894098624px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0799450800915336);">(38&nbsp;mm - 20 G)</div><div style="left: 165.76125033683644px; top: 919.1363513877659px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif;">•</div><div style="left: 173.72675828617625px; top: 919.6645109135002px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0872330167501296);"> 1 aiguille avec un </div><div style="left: 166.19240097008893px; top: 932.5990299110749px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0381708658186302);">système de sécurité </div><div style="left: 178.1568310428456px; top: 945.5335489086498px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0799450800915336);">(38&nbsp;mm - 20 G)</div><div style="left: 311.04823497709515px; top: 925.6036108865533px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif;">•</div><div style="left: 319.0137429264349px; top: 926.1317704122876px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.062111878760865);"> 1 aiguille</div><div style="left: 300.36647803826463px; top: 939.0662894098624px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0799450800915336);">(38&nbsp;mm - 20 G)</div><div style="left: 437.07356507679873px; top: 925.6036108865533px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif;">•</div><div style="left: 445.0390730261385px; top: 926.1317704122876px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.062111878760865);"> 1 aiguille</div><div style="left: 426.4025869037995px; top: 939.0662894098624px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0799450800915336);">(38&nbsp;mm - 20 G)</div><div style="left: 559.293990838049px; top: 925.6036108865533px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif;">•</div><div style="left: 567.2594987873888px; top: 926.1317704122876px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.062111878760865);"> 1 aiguille</div><div style="left: 548.6122338992186px; top: 939.0662894098624px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0799450800915336);">(38&nbsp;mm - 20 G)</div><div style="left: 654.6106170843439px; top: 919.1363513877659px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif;">•</div><div style="left: 662.5761250336836px; top: 919.6645109135002px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0872330167501296);"> 1 aiguille avec un </div><div style="left: 655.0417677175963px; top: 932.5990299110749px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0361925332208402);">système de sécurité</div><div style="left: 667.0061977903529px; top: 945.5335489086498px; font-size: 10.778765831312315px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0799450800915336);">(38&nbsp;mm - 20 G)</div><div style="left: 56.97938561034762px; top: 682.2123416868766px; font-size: 16.168148746968473px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.1668159914140057);">CONTENU DES BOÎTES DE DÉCAPEPTYL</div><div style="left: 400.2896793317165px; top: 683.3547184047425px; font-size: 9.42603071948262px; font-family: 'Open Sans', sans-serif;">®</div><div style="left: 408.7725680409593px; top: 682.2123416868766px; font-size: 16.168148746968473px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.2124249726177438);"> L.P.</div><div style="left: 15.580975478307742px; top: 1148.5499865265424px; font-size: 8.084074373484237px; font-family: 'Open Sans', sans-serif; transform: scaleX(1.0395410502887623);">REMIS BON USAGE_TRI-FR-000763_A4_09-2016.indd   1</div><div style="left: 731.393155483697px; top: 1148.5499865265424px; font-size: 8.084074373484237px; font-family: 'Open Sans', sans-serif; transform: scaleX(0.965153415833192);">29/09/2016   10:08</div><div class="endOfContent"></div></div>